Nadja I Lorenz Selected Research

Nadja I Lorenz Research Topics

8	Glioblastoma (Glioblastoma Multiforme) 09/2021 - 10/2017
8	Hypoxia (Hypoxemia) 01/2021 - 10/2017
5	Glioma (Gliomas) 01/2020 - 10/2017
2	Neoplasms (Cancer) 09/2019 - 08/2018
1	Colorectal Neoplasms (Colorectal Cancer) 10/2020
1	Carcinoma (Carcinomatosis) 10/2020
1	Starvation 08/2020
1	Tuberous Sclerosis 1 01/2019
1	Ketosis 08/2018

4	ErbB Receptors (EGF Receptor)IBA 10/2020 - 10/2017
3	Mechanistic Target of Rapamycin Complex 1IBA 09/2019 - 10/2017
3	TOR Serine-Threonine KinasesIBA 09/2019 - 10/2017
2	Serine (L-Serine)FDA Link 09/2021 - 01/2020
2	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 01/2019
2	Bevacizumab (Avastin)FDA Link 10/2020 - 10/2017
2	Glucose (Dextrose)FDA LinkGeneric 05/2020 - 08/2018
2	Adenosine Triphosphate (ATP)IBA 09/2019 - 10/2017
2	Doxycycline (Periostat)FDA LinkGeneric 01/2019 - 05/2018
1	Activating Transcription Factor 4IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020
1	4- ((3- bromophenyl)amino)- 6,7- dimethoxyquinazolineIBA 10/2020
1	Cetuximab (Erbitux)FDA Link 10/2020
1	Monoclonal AntibodiesIBA 10/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2020
1	epidermal growth factor receptor VIIIIBA 08/2020
1	Epidermal Growth Factor (EGF)IBA 08/2020
1	Glycine Hydroxymethyltransferase (Serine Hydroxymethyltransferase)IBA 01/2020
1	cbr-5884IBA 01/2020
1	Phosphoglycerate Dehydrogenase (Dehydrogenase, Phosphoglycerate)IBA 01/2020
1	dactolisibIBA 09/2019
1	MTOR InhibitorsIBA 09/2019
1	Sirolimus (Rapamycin)FDA Link 09/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Ketone BodiesIBA 08/2018
1	dabrafenibIBA 12/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2017